Tracheal aspirate surface tension in babies with hyaline membrane disease: Effects of synthetic surfactant replacement

Pediatric Pulmonology

Volumn 26, Issue 3, 1998, Pages 173-182

  McMillan, D D ^a,b   Singhal, N ^a   Shukla, A K ^a   Schurch S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

Hyaline membrane disease; Respiratory distress syndrome; Surface tension; Surfactant; Tracheal aspirate; Ventilator management

Indexed keywords

LUNG SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOTRACHEAL TUBE; FEMALE; HUMAN; HYALINE MEMBRANE DISEASE; INTRATRACHEAL DRUG ADMINISTRATION; LUNG ALVEOLUS SURFACE TENSION; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRACHEA; TREATMENT OUTCOME;

DOUBLE-BLIND METHOD; DRUG COMBINATIONS; EXUDATES AND TRANSUDATES; FATTY ALCOHOLS; FEMALE; HUMANS; HYALINE MEMBRANE DISEASE; INFANT, NEWBORN; MALE; PHOSPHORYLCHOLINE; POLYETHYLENE GLYCOLS; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; SURFACE TENSION; TRACHEA;

EID: 0031665167     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199809)26:3<173::AID-PPUL4>3.0.CO;2-M     Document Type: Article

References (52)

1. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child. 1959; 97:517-523.
2. Hildebran JN, Goerke J, Clements JA. Pulmonary surface film stability and composition. J Appl Physiol. 1979; 47:604-611.
3. Notter RH, Finkelstein JN. Pulmonary surfactant: An interdisciplinary approach. J Appl Physiol. 1984; 57:1613-1624.
4. Enhorning GA. A pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol. 1977; 43:198-201.
5. Sher G, Statland BE, Freer DE, Kraybill EN. Assessing fetal lung maturation by the foam stability index. Obstet Gynecol. 1978; 52:673-677.
6. Gluck L, Kulovich MV, Borer RC, Brenner PH, Anderson GG, Spellacy WN. Diagnosis of the respiratory distress syndrome by amniocentesis. Am J Obstet Gynecol. 1971; 109:440-445.
7. Torday J, Carson L, Lawson EE. Saturated phosphotidylcholine in amniotic fluid and prediction of respiratory distress syndrome. N Engl J Med. 1979; 301:1013-1018.
8. Hallman M, Kulovich M, Kirkpatrick E, Sugarman RG, Gluck L. Phosphatidylinositol and phosphatidylglycerol in amniotic fluid: Indices of lung maturity. Am J Obstet Gynecol. 1976; 125:613-617.
9. James DK, Chiswick ML, Harkes A, William M, Hallworth J. Non-specificity of surfactant deficiency in neonatal respiratory disorders. Br Med J. 1984; 288:1635-1638.
10. Obladen M, Merritt TA, Gluck L. Alterations of pulmonary surfactant maturation in stressed pregnancies: A study of neonatal lung effluent. Am J Obstet Gynecol. 1979; 135:1079-1085.
11. Obladen M, Gluck L. RDS and tracheal phospholipid composition in twins: Independent of gestational age. J Pediatr. 1977; 90:799-802.
12. D'Costa M, Dassin R, Bryan H. Lecithin/sphingomyelin ratios in tracheal aspirates from newborn infants. Pediatr Res. 1987; 22: 154-157.
13. Jacobson W, South M, Hughes G, Davies R, Morley C. Tracheal aspirates from neonates during endotracheal intubation: Detection of surfactant by polarized light microscopy. J Pediatr. 1988; 113: 368-372.
14. Shelley SA, Kovacevic M, Pagiga JE, Balis JU. Sequential changes of surfactant phosphatidylcholine in hyaline-membrane disease of the newborn. New Engl J Med. 1979; 300:112-116.
15. Ikegami M, Jacobs H, Jobe A. Surfactant function in respiratory distress syndrome. J Pediatr. 1983; 102:443-447.
16. Schürch S, Bachofen H, Goerke J, Possmayer F. A captive bubble method reproduces the in situ behavior of lung surfactant monolayers. J Appl Physiol. 1989; 67:2389-2396
17. Bose C, Corbet A, Bose G, Garcia-Prats J, Lombardy L, Wold D, Danlon D, Long W. Improved outcome at 28 days of very low birth weight infants treated with a single dose of synthetic surfactant. J Pediatr. 1990; 117:947-953.
18. Corbet AJ, Goldman SA, Lombardy L, Mammel MA, Long WA. Decreased mortality in small premature infants treated at birth with single dose of synthetic surfactant: A multicentre trial. J Pediatr. 1991; 118:277-284.
19. Phibbs RH, Ballard RA, Clements JA, Heilbron DC, Phibbs CS, Schlueter MA, Sniderman SH, Tooley WH, Wakely A. Initial clinical trial of EXOSURF, a protein-free synthetic surfactant for prophylaxis and early treatment of hyaline membrane disease. Pediatrics. 1991; 88:1-9.
20. Long WA, Thompson T, Sundell H, Schumacher R, Volberg F, Guthrie R. Effects of two rescue doses of a synthetic surfactant on mortality in 700-1300 gm infants with RDS. J Pediatr. 1991; 118:595-605.
21. Long WA, Corbet AJ, Cotton R, Courtney S, McGuiness G, Walter D, Watts J, Smyth J, Bard H, Chernick V. A controlled trial of synthetic surfactant in infants weighing 1250 g or more. N Engl J Med. 1991; 325:1696-1703.
22. Schürch S, Bachofen H, Goerke J, Green F. Surface properties of rat pulmonary surfactant studied with the captive bubble method: Adsorption, hysteresis stability. Biochem Biophys Acta. 1992; 1103:127-136.
23. Schoel WM, Schürch S, Goerke J. The captive bubble method for the evaluation of pulmonary surfactant: Surface tension, area, and volume calculations. Biochim Biophys Acta. 1994; 1200:281-290.
24. Schürch S, Schürch D, Curstedt T, Robertson B. Surface activity of lipid extract surfactant in relation to film area compression and collapse. J Appl Physiol. 1994; 77:974-986.
25. Clements JA. Functions of the alveolar lining layers. Am Rev Respir Dis. 1977; 115:67-71.
26. Schürch S, Possmayer F, Cheng S, Cockshutt AM. Pulmonary SP-A enhances adsorption and appears to induce surface sorting of lipid extract surfactant. Am J Physiol. 1992; 263:L210-L218.
27. Schürch S. Surface tension properties of surfactant. Clin Perinatol. 1993; 20:669-672.
28. Ikegami M, Jobe A, Jacobs H, Lam H. A protein from airways of premature lambs that inhibits surfactant function. J Appl Physiol. 1984; 57:1134-1142.
29. Ikegami M, Jobe A, Berry D. A protein that inhibits surfactant in respiratory distress syndrome. Biol Neonate. 1986; 50:121-129.
30. Robertson B, Berry D, Curstedt T, Grossman G, Ikegami M, Jacobs H, Jobe A, Jones S. Leakage of protein in the immature rabbit lung: Effect of surfactant replacement. Respir Physiol. 1985; 61:265-276.
31. Green FHY, Schüren S, DeSanctis GT, Wallace JA, Cheng WS, Prior M. Effects of hydrogen sulfide exposure on surface properties of lung surfactant. J Appl Physiol. 1991; 70:1943-1949.
32. Slomiany A, Murty VLN, Aono M, Snyder C, Herp A, Slomiany BL. Lipid composition of tracheal secretions from normal individuals and patients with cystic fibrosis. Biochim Biophys Acta. 1982; 710:106-111.
33. Girod S, Funchey C, Galabert C, Lebonvallet S, Bonnet N, Platon D, Puchelle E. Identification of phospholipid secretory granules of human submucosal gland respiratory cells. J Histochem Cytochem. 1991; 39:193-198.
34. Bernhard W, von der Hardt H. Bronchial surfactant phospholipid classes and phosphatidylcholine molecular species as indicators of its alveolar origin. Appl Cardiopulmon Pathophysiol. 1995; 5:6-7.
35. Robertson B, Lachmann B. Experimental evaluation of surfactants for replacement therapy. Exp Lung Res. 1988; 14:279-310.
36. Possmayer F, Yu SH, Weber JM, Harding PGR. Pulmonary surfactant. Can J Biochem Cell Biol. 1984; 62:1121-1133.
37. Bachofen H, Schüren S, Urbinelli M, Weibel ER. Relations among alveolar surface tension, surface area, volume, and recoil pressure. J Appl Physiol. 1987; 62:1878-1887.
38. Wright JR, Clements JA. Metabolism and turnover of lung surfactant. Am Rev Respir Dis. 1987; 135:426-444.
39. Power JHT, Barr HA, Jones ME, Nicholas TE. Changes in surfactant pools after a physiologic increase in alveolar surfactant. J Appl Physiol. 1987; 63:1902-1911.
40. Faridy EE, Thliveris JA. Rate of secretion of lung surfactant before and after birth. Respir Physiol. 1987; 68:269-277.
41. Dunn M, Zayack D, Kim E, D'Costa M. Serial lecithin/ sphingomyelin ratios in tracheal aspirates from surfactant treated premature infants. Clin Invest Med. 1992; 15:A124.
42. Bui KC, Walther FJ, David-Ku R, Gang M, Warburton D. Phospholipid and surfactant Protein A concentrations in tracheal aspirates from infants requiring extracorporeal membrane oxygenation. J Pediatr. 1992; 121:271-274.
43. Bachofen H, Schürch S, Urbinelli M. Surfactant and alveolar micromechanics. Prog Respir Res Basel. 1990; 25:158-167.
44. Metcalfe IL, Burgoyne R, Enhorning G. Surfactant supplementation in the preterm rabbit: Effects of applied volume on compliance and survival. Pediatr Res. 1982; 16:834-839.
45. Durand DJ, Clyman RI, Heymann MA, Clements JA, Mauray F, Kitterman J, Ballard P. Effects of a protein-free, synthetic surfactant on survival and pulmonary function in preterm lambs. J Pediatr. 1985; 107:775-780.
46. Svenningsen NW, Björklund L, Vilstrup C, Werner O. Lung mechanics (FRC and static pressure-volume diagram) after endotracheal surfactant administration: Preliminary observations. Biol Neonate. 1992; 61:44-47.
47. Couser RJ, Ferrara TB, Ebert J, Hoekstra RE, Fangman JJ. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease. J Pediatr. 1990; 116:119-124.
48. Cotton RB, Olsson T, Law AB, Parker RA, Lindstrom DP, Silberberg AS, Sundell HW, Sandberg K. The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease. Pediatr Res. 1993; 34:495-501.
49. Armsby DH, Bellon G, Carlisle K, Rector D, Baldwin R, Long W, Stevenson DK, Ariagno RL. Delayed compliance increase in infants with respiratory distress syndrome following synthetic surfactant. Pediatr Pulmonol. 1992; 14:206-213.
50. Bhutani VK, Abbasi S, Long WA, Gerdes JS. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant. J Pediatr. 1992; 120:S18-S29.
51. Davis JM, Veness-Meehan K, Notter RH, Bhutani VK, Kendig JW, Shapiro DL. Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome. N Engl J Med. 1988; 319:476-479.
52. Goldsmith LS, Greenspan JS, Rubenstein F, Wolfson MR, Schaffer TH. Immediate improvement in lung volume after exogenous surfactant: Alveolar recruitment versus increased distention. J Pediatr. 1991; 119:424-428.